Status:
COMPLETED
Enhancing Inhibition With tDCS in Low Back Pain
Lead Sponsor:
Aalborg University
Collaborating Sponsors:
Danish National Research Foundation
Conditions:
Low Back Pain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This cross-over study intends to use consecutive days of active versus sham transcranial direct current stimulation (tDCS) to enhance descending inhibition and look at resulting clinical effects in pe...
Eligibility Criteria
Inclusion
- Otherwise healthy men and women
- Aged 18-60 years
- Continuous pain (\>3days pain/week) episode lasting at least 3 months, sufficient to limit daily activities
- Pain in the region posteriorly between the inferior border of the 12th rib and the lower gluteal fold (low back pain) at the time of recruitment
- Able to speak, read and understand English
Exclusion
- Pregnancy
- Low back pain associated with menstruation
- Currently seeking active treatment for low back pain
- Red flags symptoms (i.e. fever, malaise, progressive neurologic deficit, significant trauma, prolonged corticosteroid use or osteoporosis, pain worst at night, urinary or faecal incontinence, or unintended weight loss)
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Current or previous neurologic, musculoskeletal, mental, or other illnesses which may affect the trial
- Current or previous chronic or recurrent pain condition other than low back pain
- Current regular use of analgesic medication or other medication which may affect the trial
- Lack of ability to cooperate
Key Trial Info
Start Date :
April 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 7 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03864822
Start Date
April 29 2019
End Date
October 7 2020
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CNAP, SMI, Aalborg University
Aalborg, Denmark, 9000